{"cord_uid":"yy77veid", "sourcedb":"PMC", "sourceid":"PMC6817825", "divid":10, "text":"The introduction would benefit from a statement regarding the motivating advantages of an RNP-based strategy, e.g. decreased risks (vs. virus, as noted in the discussion) and ease of manufacture (vs. viral or nanoparticle strategies). Perhaps the following sentence, which is currently in the Results section, could simply be moved to the introduction: "RNPs comprised of Cas nucleases and guide RNAs (gRNA) are of interest for therapeutic gene editing because of their rapid effect and transient nuclease activity [41] [42] [43] [44] ."", "project":"cdlai_CORD-19", "denotations":[]}